Celltrion secures $730 mn to buy biosimilar unit shares, pursue M&A
Celltrion Holdings Co. has secured 1 trillion won ($732 million) in fresh funding and plans to spend half of it this year to buy shares in its biosi...
S.Korea corporate law reform gains bipartisan support
South Korea's ruling Democratic Party’s proposal to strengthen protections for minority investors and enhance board independence has secured t...
Tencent eyes 2nd-largest stake in Kakao Mobility amid broader Korea push
Chinese tech giant Tencent Holdings Ltd. has emerged as a surprise contender in a race to acquire a roughly 40% stake in Kakao Mobility Corp., the o...
CJ CGV under pressure to shed China, Vietnam cinema assets
MBK Partners and Mirae Asset Securities Co. are considering divesting of their holdings in CGI Holdings Co., which oversees CJ CGV Co.’s multi...
NPS to lift stock holdings to 55% by 2030, raising risk appetite
The National Pension Service (NPS) plans to raise its equity allocation to about 55% of its assets by 2030 from 40.4% as of the end of February, Sou...
Tencent to become SM Entertainment's No. 2 shareholder via HYBE deal
Tencent Music Entertainment Group is set to become the second-largest shareholder of SM Entertainment Co. by acquiring HYBE Co.'s remaining shares i...
Celltrion shares rise after bonus issue announcement
Celltrion Inc., South Korea’s largest biosimilar developer, will issue bonus shares to bolster its stock performance, which has been in the do...
NPS gobbles up Korea’s top 4 financial holding stocks
South Korea’s largest institutional investor, the National Pension Service (NPS), remains a strong backer of the country’s top four fina...
Samsung gears up for foray into space infrastructure industry
Samsung Group is stepping up efforts to venture into the space infrastructure industry, a sector analysts say remains a blue ocean where South Korea...
POSCO Future M to raise $771 million to bolster battery materials business
POSCO Future M Co., South Korea’s leading battery materials maker, is set to raise 1.1 trillion won ($771 million) through a rights offering a...
Korean LCCs boost travel demand to global tourist hubs
South Korean low-cost carriers (LCCs), including Air Premia Inc. and Air Busan Co., have been expanding into underserved smaller cities, but also dr...
Hankook & Company to set up CVC with $11 mn in funding
Hankook & Company Co., the holding company of Hankook Tire & Technology Co., announced Thursday a plan to launch a wholly owned corporate ve...
Celltrion unveils cancer medicine to expand new drug pipelines
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
S.Korea’s top 4 financial holding firms cheer upbeat Q1 results
South Korea’s top four financial holding companies – Shinhan, KB, Hana and Woori – reported stellar earnings for the first quarter...
Celltrion expands footprint in Latin America with flagship oncology drugs
South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...
Celltrion wins Australian approval for eye, bone disease biosimilars
Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...
S.Korean President Yoon Suk Yeol ousted; new presidential election coming
South Korea’s Constitutional Court permanently removed President Yoon Suk Yeol from office on Friday, making him the country’s second pr...
S.Korean court to rule on impeached President Yoon’s fate April 4
South Korea’s Constitutional Court on Friday will give its ruling on President Yoon Suk Yeol, who was impeached in December for declaring mart...
Hanwha gears up for 3rd-generation leadership with chairman’s stake gift
South Korea’s chemical-to-defense conglomerate Hanwha Group Chairman Kim Seung-youn will hand over half of his holdings in the conglomerate&rs...
Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US
South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...
NPS to buy stake in Australia’s Metrics to expand alternative investments
South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, has agreed to buy a stake in Australian asset mana...
Celltrion to cancel $140 mn in treasury shares, stock up
South Korea’s leading biosimilar drug developer Celltrion Inc. announced on Friday a plan to cancel $140 million worth of treasury shares to i...
Hanwha Energy begins IPO process, key to 3rd-generation shift
Hanwha Energy Corp., wholly owned by Hanwha Group Chairman Kim Seung-youn’s three sons, has embarked on the process of going public – a ...
Samsung, Celltrion lead biosimilar market in Europe, US
Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...
Affinity, GIC sell out of Kyobo Life; Chairman Shin seeks holding firm, M&A
Affinity Equity Partners and Singapore’s sovereign wealth fund GIC have sold their entire stake in Kyobo Life Insurance Co., exiting from thei...
LG Electronics hits record sales in India, paving way for 2025 IPO
LG Electronics Inc. posted its largest-ever sales in India in 2024, providing a boost to the planned initial public offering of its Indian unit this...
Celltrion wins EU approval for autoimmune disease treatment Avtozma
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Meritz leaps to No. 2 financial holding firm in South Korea
Meritz Financial Group Inc., once a medium-sized financial service firm in South Korea, has become the second-most valuable publicly traded financia...
KKR recoups $206 mn in block sale of HD Hyundai Marine shares
Global private equity firm KKR & Co. Inc. has succeeded in cashing out of its stake in HD Hyundai Marine Solution Co. for 295 billion won ($206 ...
Meritz cheers record profit in 2024, boasts top 3 market cap
Meritz Financial Group Inc. has reported its best-ever net profit for last year thanks to handsome gains from investments by its insurance and secur...
